Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

White Adipose Tissue LDL Receptors and Omega-3 as Modulators of the Risk for Type 2 Diabetes in Subjects With Normal Plasma LDL Cholesterol

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04485871
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:14.256553+00:00
Published At
2026-03-12T00:00:00+00:00
Record Updated At
2026-03-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Type 2 Diabetes", "Inflammation", "Insulin Sensitivity/Resistance", "Fatty Acids, Omega-3"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-12"
protocolSection.identificationModule.nctId
"NCT04485871"
protocolSection.identificationModule.officialTitle
"White Adipose Tissue LDL Receptors and Omega-3 as Modulators of the Risk for Type 2 Diabetes in Subjects With Normal Plasma LDL Cholesterol"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Type 2 Diabetes (protocolSection.conditionsModule.conditions)
  • Inflammation (protocolSection.conditionsModule.conditions)
  • Insulin Sensitivity/Resistance (protocolSection.conditionsModule.conditions)
  • Fatty Acids, Omega-3 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.